{
  "@context": "aku-v2",
  "@type": "concept",
  "@id": "medicine:vascular:complications:contrast-induced-nephropathy:cin-001",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-05T04:40:00.000Z",
    "contributors": ["copilot"],
    "confidence": 0.95,
    "status": "validated",
    "board_yield": "HIGH"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/complications/contrast-induced-nephropathy",
    "type": "definition",
    "difficulty": "intermediate",
    "importance": "high"
  },
  "content": {
    "title": "Contrast-Induced Nephropathy (CIN) / Contrast-Induced Acute Kidney Injury (CI-AKI)",
    "definition": "Acute decline in renal function occurring within 48-72 hours of intravascular contrast administration, defined as increase in serum creatinine ≥0.5 mg/dL or ≥25% from baseline. Common complication of angiography and CTA with significant morbidity implications.",
    "key_concepts": [
      {
        "term": "Definition Criteria",
        "description": "Increase in serum creatinine ≥0.5 mg/dL (or ≥25% relative increase) within 48-72 hours of contrast exposure in absence of other causes of AKI"
      },
      {
        "term": "Pathophysiology",
        "description": "Contrast causes renal vasoconstriction → medullary hypoxia; direct tubular toxicity; oxidative stress; osmotic effects. Combination leads to acute tubular necrosis"
      },
      {
        "term": "Risk Factors",
        "description": "Pre-existing CKD (strongest risk factor); diabetes (especially with CKD); heart failure; volume depletion; high contrast volume; repeat contrast exposure; nephrotoxic drugs (NSAIDs, aminoglycosides)"
      },
      {
        "term": "Contrast Volume",
        "description": "Higher volume = higher risk; rule of thumb: contrast volume (mL) should not exceed 5 × body weight (kg) ÷ creatinine. Minimize volume; use dilute contrast"
      },
      {
        "term": "Contrast Types",
        "description": "Iso-osmolar (Iodixanol/Visipaque) and low-osmolar (Iopamidol, Iohexol) are safer than high-osmolar contrast; iso-osmolar may be preferred in high-risk patients"
      },
      {
        "term": "Prevention - Hydration",
        "description": "IV normal saline (1 mL/kg/hr for 6-12 hours before and after) is the best-proven preventive measure; oral hydration less effective"
      },
      {
        "term": "Prevention - N-Acetylcysteine",
        "description": "NAC 600-1200mg PO BID before and after contrast has been used; evidence is mixed/weak; inexpensive and low risk so often given"
      },
      {
        "term": "Prevention - Sodium Bicarbonate",
        "description": "Some studies suggest benefit of bicarbonate infusion over saline; evidence inconsistent; reasonable alternative if concerned about acidosis"
      },
      {
        "term": "Hold Nephrotoxic Medications",
        "description": "Hold metformin before and 48 hours after contrast (lactic acidosis risk if AKI develops); hold NSAIDs; use caution with ACE inhibitors/ARBs"
      },
      {
        "term": "Prognosis",
        "description": "Usually reversible with peak creatinine at 3-5 days, recovery by 7-10 days; however, increased risk of long-term CKD progression, dialysis, and mortality"
      }
    ],
    "clinical_features": {
      "snomed_codes": ["51292008", "236428008"],
      "icd_10_codes": ["N14.1", "N17.0"],
      "symptoms": ["Usually asymptomatic initially", "May develop oliguria", "Signs of uremia if severe"],
      "signs": ["Rising creatinine 48-72h post-contrast", "Oliguria", "Fluid overload if severe"],
      "risk_factors": ["CKD (eGFR <60)", "Diabetes + CKD", "Heart failure", "Dehydration", "High contrast volume", "Nephrotoxic drugs"]
    },
    "differential_diagnosis": [
      "Prerenal azotemia",
      "Cholesterol embolization (delayed onset)",
      "Aortic dissection with renal malperfusion",
      "Drug-induced nephrotoxicity",
      "Cardiorenal syndrome"
    ]
  },
  "relationships": {
    "skos:broader": ["medicine:vascular:complications:procedural"],
    "skos:related": [
      "medicine:nephrology:acute-kidney-injury",
      "medicine:radiology:contrast-agents",
      "medicine:vascular:procedures:angiography"
    ],
    "skos:narrower": []
  },
  "pedagogical": {
    "learning_objectives": [
      "Define CI-AKI and identify high-risk patients",
      "Know the best preventive strategy (IV hydration)",
      "Understand contrast volume limitations",
      "Recognize the timeline (creatinine peaks 3-5 days)"
    ],
    "clinical_pearls": [
      "CKD is the strongest risk factor - know baseline creatinine",
      "IV normal saline is the best-proven prevention",
      "Rule of thumb: contrast mL < 5 × weight(kg) ÷ creatinine",
      "Creatinine peaks at 3-5 days, usually recovers by 7-10 days",
      "Hold metformin 48 hours post-contrast (lactic acidosis if AKI)",
      "NAC is cheap and low-risk, but evidence is weak"
    ],
    "common_mistakes": [
      "Not checking baseline renal function before contrast",
      "Inadequate pre-hydration in high-risk patients",
      "Using excessive contrast volume",
      "Not holding metformin appropriately",
      "Confusing CIN (48-72h onset) with cholesterol embolization (delayed, persistent)"
    ]
  }
}
